Evidence map›Paper›PMID 33782385›Full record

SynthesisTranslational psychiatry2021

Genetic factors influencing a neurobiological substrate for psychiatric disorders.

Till F M Andlauer, Thomas W Mühleisen, Felix Hoffstaedter, Alexander Teumer, Katharina Wittfeld, Anja Teuber, Céline S Reinbold, Dominik Grotegerd, Robin Bülow, Svenja Caspers and 18 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 11 institutions in 5 countries.

Till F M Andlauer *Max Planck Institute of Psychiatry, Munich, Germany.ORCID 0000-0002-2917-5889
Thomas W Mühleisen *Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.ORCID 0000-0002-6057-5952
Felix HoffstaedterInstitute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.ORCID 0000-0001-7163-3110
Alexander TeumerInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-8309-094X
Katharina WittfeldGerman Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.ORCID 0000-0003-4383-5043
Anja TeuberInstitute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Céline S ReinboldDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Dominik GrotegerdDepartment of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Robin BülowInstitute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
Svenja CaspersInstitute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Udo DannlowskiDepartment of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Stefan HermsDepartment of Biomedicine, University of Basel, Basel, Switzerland.ORCID 0000-0002-2786-8200
Per HoffmannInstitute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Tilo KircherDepartment of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
Heike MinnerupInstitute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Susanne MoebusInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
Igor NenadićDepartment of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
Henning TeismannInstitute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.ORCID 0000-0001-5807-5572
Uwe VölkerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Amit EtkinDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, 94304, USA.
Klaus BergerInstitute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Hans J GrabeDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0003-3684-4208
Markus M NöthenDepartment of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Katrin AmuntsInstitute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.ORCID 0000-0001-5828-0867
Simon B EickhoffInstitute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Philipp G SämannMax Planck Institute of Psychiatry, Munich, Germany.
Bertram Müller-Myhsok *Max Planck Institute of Psychiatry, Munich, Germany.
Sven Cichon *Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany. s.cichon@fz-juelich.de.ORCID 0000-0002-9475-086X
Forschungszentrum Jülich · DEUniversity of Münster · DEUniversitätsmedizin Greifswald · DEUniversity of Bonn · DEPhilipps University of Marburg · DEInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DEMax Planck Institute of Psychiatry · DENeurosciences Institute · USTUM Klinikum · DEUniversity of Liverpool · GBUniversity of Oslo · NO

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ER1205Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ER1506Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZX1314ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZX1614JBundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZZ0103Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZZ0403Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZZ1804ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01ZZ9603Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 03IS2061ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 03ZIK012Deutsche Forschungsgemeinschaft (German Research Foundation) DA 1151/5-1Deutsche Forschungsgemeinschaft (German Research Foundation) DA 1151/5-2Deutsche Forschungsgemeinschaft (German Research Foundation) FOR2107: NO246/10-1Deutsche Forschungsgemeinschaft (German Research Foundation) KI 588/14-1Deutsche Forschungsgemeinschaft (German Research Foundation) KI 588/14-2Deutsche Forschungsgemeinschaft (German Research Foundation) MU1315/8-2EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 785907EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 826421EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) EU RIA 733161Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 156791
6 · The paper itself

Abstract

A retrospective meta-analysis of magnetic resonance imaging voxel-based morphometry studies proposed that reduced gray matter volumes in the dorsal anterior cingulate and the left and right anterior insular cortex-areas that constitute hub nodes of the salience network-represent a common substrate for major psychiatric disorders. Here, we investigated the hypothesis that the common substrate serves as an intermediate phenotype to detect genetic risk variants relevant for psychiatric disease. To this end, after a data reduction step, we conducted genome-wide association studies of a combined common substrate measure in four population-based cohorts (n = 2271), followed by meta-analysis and replication in a fifth cohort (n = 865). After correction for covariates, the heritability of the common substrate was estimated at 0.50 (standard error 0.18). The top single-nucleotide polymorphism (SNP) rs17076061 was associated with the common substrate at genome-wide significance and replicated, explaining 1.2% of the common substrate variance. This SNP mapped to a locus on chromosome 5q35.2 harboring genes involved in neuronal development and regeneration. In follow-up analyses, rs17076061 was not robustly associated with psychiatric disease, and no overlap was found between the broader genetic architecture of the common substrate and genetic risk for major depressive disorder, bipolar disorder, or schizophrenia. In conclusion, our study identified that common genetic variation indeed influences the common substrate, but that these variants do not directly translate to increased disease risk. Future studies should investigate gene-by-environment interactions and employ functional imaging to understand how salience network structure translates to psychiatric disorder risk.

Indexed as

Bipolar DisorderMajor Depressive DisorderSchizophreniaGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotideRetrospective Studies

Identifiers

PMID33782385
PMCPMC8007575
OpenAlexW3141132878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.